Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study

The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.

Leave a Reply

Your email address will not be published. Required fields are marked *

TODAYNEO